Antibody and CD8+ T Cell Responses Against HER2/neu Required for Tumor Eradication After DNA Immunization With a FLT-3 Ligand Fusion Vaccine
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-0258
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2007
Authors
Publisher
American Association for Cancer Research (AACR)